MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BTAI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioXcel Therapeutics (BTAI) Ownership - Who owns BioXcel Therapeutics?

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
29
Web
https://www.bioxceltherapeutics.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
32.11M
P/E Ratio
N/A
Total Cash
17.18M
Projected Growth
N/A
Total Debt
100.29M
Revenue
680K
Risk (Beta)
-0.23
Dividend Yield
N/A
Total Cash/Share
0.56
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BTAI
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for BTAI
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
29
Web
https://www.bioxceltherapeutics.com